awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52638921-A9B54B49-6E67-4153-9ED0-FFE40307B5AC
Q52638921-A9B54B49-6E67-4153-9ED0-FFE40307B5AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52638921-A9B54B49-6E67-4153-9ED0-FFE40307B5AC
Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.
P2860
Q52638921-A9B54B49-6E67-4153-9ED0-FFE40307B5AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52638921-A9B54B49-6E67-4153-9ED0-FFE40307B5AC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8295daf4ed5acf90758b0601dec82cb96fdcfeea
P2860
Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.